Abstract:Abstract Introduction Sleep disorders, the most neglected public-health issues, are threatening overall health. It is tightly associated with the individual’s exposures to the light/dark (LD)-cycles linked to their circadian rhythms. Lifestyle, shift-work, frequent travels, and post-pandemic-stress lead unintentional compromise of sleep, thus circadian homeostasis. Melatonin (MT), a pivotal natural hormone for circadian and sleep health, attains acrophase in the dark. MT mediates LD-triggered circadian rhythms through its dynamic expressions. Circadian phases are greatly reflected by MT-dynamics. Dim-light-MT-onsets (DLMO) act as a marker, reporting internal circadian-timing in mammals. Estimating this is essential in therapeutic-designing against misaligned circadian conditions. Despite many experimental approaches, there is still a slit hacking the MT-dynamics from molecules to systems. Inclusive perspectives on endogenous factors affecting MT’s synthesis, secretions and bioavailability over time-course are not extensively exposed. MT-dynamics has multiplexed stochastic interactions across numerous genes, TFs, and regulators, and they are coupled non-linearly. Small changes used to compound through the genetic networks and reflected in systems-wide events marking distinct signalling response dynamics. Understanding such responses is challenging yet imperative. A robust quantitative model is inevitable to investigate such stochastic intricacy. Methods We proposed a quantitative framework to model MT signalling networks using diverse kinetic parameters linked in its genetic circuits and perturbing them must alter the MT-dynamics. We used a robust computational approach, LogicTRN to decode the systematic controls of the MT-dynamics. It combines multi-layered transcriptome-wide data as input. Computing this returned the regulatory TF-logics in the transcriptional regulatory networks for MT. We developed transcriptional simulations with virtual-knockout mutants and performed genetic network perturbation study. Results The results showed the reconstruction of robust quantitative regulatory networks decrypting transcriptional controls for MT-dynamics to estimate the influence of the multiple kinetically distinct inputs affecting those dynamics. This offered competitive advantages in terms of scalability, robustness, and iterations to characterize the effective molecular-targets to modulate the genetic circuit of MT-dynamics effectually. Conclusion Quantitative reconstruction and characterization of the regulatory interactome of MT may facilitate us to strategize the adjustments of regulatory controls to effectively modulate MT-dynamics. This foundation may enhance the advancement of circadian and sleep medicine in future. Support (if any):

Melatonin, Melatonin Receptors and Sleep: Moving Beyond Traditional Views

Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep

Melatonin as a Mediator of the Gut Microbiota-Host Interaction: Implications for Health and Disease

A Review of Melatonin, Its Receptors and Drugs

Structural Basis of the Ligand Binding and Signaling Mechanism of Melatonin Receptors

Melatonin receptor structure and signaling

The location, physiology, pathology of hippocampus Melatonin MT2 receptor and MT2-selective modulators

A review of sleep disorders and melatonin

Structural basis of ligand recognition at the human MT1 melatonin receptor

Quantum mechanics insights into melatonin and analogs binding to melatonin MT1 and MT2 receptors

New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation

Melatonin and its analogs in insomnia and depression

Melatonin: Pharmacology, Functions and Therapeutic Benefits

Melatonin Target Proteins: Too Many or Not Enough?

Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders

Melatonin and Depression: A Translational Perspective From Animal Models to Clinical Studies

Melatonin: Physiological effects in humans

015 Modulating melatonin dynamics at transcription level using virtual knockout approaches: an advanced perspective in sleep medicine

Selective Enhancement of REM Sleep in Male Rats through Activation of Melatonin MT1 Receptors Located in the Locus Ceruleus Norepinephrine Neurons

Thirty‐seven years of MT1 and MT2 melatonin receptor localization in the brain: Past and future challenges

Industrial and academic approaches to the search for alternative melatonin receptor ligands: An historical survey